ECJ holds that human parthenotes incapable of development into a human being are not excluded from patentability | Practical Law
The ECJ has followed the opinion of the Advocate General in deciding that the court's decision in Brüstle did not exclude from patentability under the Biotechnology Directive parthenotes, derived from a human ovum by parthenogenesis, which are incapable of developing into a human being. (International Stem Cell Corporation v Comptroller General of Patents, Case C-364/13, 18 December 2014.)